Mirum Pharmaceuticals (MIRM) Stock News
$MIRM · NASDAQ · HEALTHCARE · 1 stories in 30 daysBORSA has published 1 story on Mirum Pharmaceuticals (MIRM) in the past 30 days. BORSA’s news read on MIRM is balanced at 50/100, based on 1 company event over the past 7 days. Mirum Pharmaceuticals last reported quarterly results on Aug 5, 2026, for the quarter ended Jun 30, 2026.
The wire on $MIRM
newest first · updated · direct subject stories onlyMirum Pharmaceuticals granted inducement awards to 17 new employees on Nov. 10. Awards include options for 26,126 shares at $94.42 and 34,386 RSUs, vesting over three to four years. The grants are standard for attracting talent and do not reflect a change in business outlook.
neutral 50 · impact 10The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Mirum Pharmaceuticals (MIRM) stock: common questions
What is the latest Mirum Pharmaceuticals stock news?
The highest-impact MIRM story BORSA published in the past 30 days:
· Mirum Pharmaceuticals grants inducement stock options and RSUs to 17 new employees